Drug intelligence / Profile preview

IUB STELLA

Development stage: Preclinical
Lead developer: OCON Therapeutics
Modality: Device-based Delivery → Drug Delivery Systems
Administration: Implant

Overview

IUB STELLA is an intrauterine drug delivery system developed by OCON Therapeutics for the treatment of endometriosis. It is based on the company's proprietary IUB (Intra-Uterine Ball) platform, which is designed for sustained drug release within the uterus. The capital raised by OCON Therapeutics is being used to advance the development of IUB STELLA.

Beyond the preview

Go deeper on IUB STELLA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IUB STELLA.

Explore the full profile